Raymond James Upgrades Gilead Sciences to Outperform, Announces $93 Price Target
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Steven Seedhouse has upgraded Gilead Sciences (NASDAQ:GILD) from Market Perform to Outperform and set a price target of $93.
July 08, 2024 | 9:33 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Raymond James has upgraded Gilead Sciences from Market Perform to Outperform, setting a price target of $93. This upgrade is likely to positively impact Gilead's stock price in the short term.
Analyst upgrades typically lead to positive short-term movements in stock prices. The new price target of $93 suggests confidence in Gilead's future performance, which is likely to attract investor interest.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100